Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
B., Wilson, L
Week-by-week dosage comparison Weight loss comparison at matched timepoints *Tirzepatide 24 and 48-week figures estimated from SURMOUNT-1 trajectory data, as primary endpoint was 72 weeks
So, you know, theres a lot of factors to think about here
These trials were on people with type 2 diabetes
This launch reinforces our commitment to Tevas complex generic portfolio and to sustaining Tevas generics powerhouse as part of our pivot to growth strategy
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
